Phase 1 trial of decitabine and bortezomib in high risk Acute Myeloid Leukemia (AML)

Category Primary study
JournalBlood
Year 2010
This article has no abstract
Epistemonikos ID: 2c7d969a850365e8792bf248d616fa7e91a0d8fc
First added on: Feb 05, 2025